The Impact of Positron Emission Tomography with 18F-Fluciclovine on the Management of Patients with Biochemical Recurrence of Prostate Cancer: Results from the LOCATE Trial

The prospective, multicenter LOCATE trial assessed the impact of positron emission tomography/computed tomography (PET/CT) with 18F-fluciclovine on management plans for patients with biochemical recurrence (BCR) of prostate cancer after curative-intent primary therapy.

Source: The Journal of Urology - September 1, 2018 Category: Urology & Nephrology Authors: Gerald L. Andriole, Lale Kostakoglu, Albert Chau, Fenghai Duan, Umar Mahmood, David A. Mankoff, David M. Schuster, Barry A. Siegel, LOCATE study group Source Type: research